SOMAVAC® Selected to Present at TLSF 2024
SOMAVAC® Medical Solutions is thrilled to announce that it has been chosen to present at Texas Life Science Forum (TLSF) on November 7, 2024. This event brings together industry leaders, emerging life science companies, academic experts, and investors to explore innovations shaping the future of healthcare.
Elizabeth Hoff, CEO of SOMAVAC®, to Lead the Presentation
Elizabeth Hoff, CEO of SOMAVAC® Medical Solutions, will represent the company at TLSF, showcasing our groundbreaking negative pressure wound therapy device and its transformative impact on post-surgical recovery. In her presentation, Elizabeth will discuss how SOMAVAC® is revolutionizing post-operative seroma management, improving patient outcomes, and reshaping the future of post-surgical care.
“We are honored to be part of the Texas Life Science Forum, where innovators from across the life science and healthcare sectors come together,” said Elizabeth Hoff. “Our presentation will highlight SOMAVAC®’s mission to revolutionize patient recovery and our commitment to advancing care through innovation.”
About the Texas Life Science Forum
The 13th Annual Texas Life Science Forum, co-hosted by BioHouston and Rice Alliance, is Texas’ premier life science and health-tech event. Taking place on November 7, 2024, the forum unites industry professionals, investors, and executives, providing a platform for innovative companies to showcase their advancements to leaders in healthcare and life sciences. For SOMAVAC®, it offers a unique opportunity to advocate for improved solutions in post-surgical recovery.
Join SOMAVAC® at TLSF on November 7, 2024
Stay tuned for updates and insights from the event as we continue our mission to revolutionize patient recovery.